{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:32:20Z","timestamp":1783488740857,"version":"3.55.0"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","funder":[{"DOI":"10.13039\/100012297","name":"Society of Family Planning","doi-asserted-by":"crossref","award":["SPRF15-MSD3"],"award-info":[{"award-number":["SPRF15-MSD3"]}],"id":[{"id":"10.13039\/100012297","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To evaluate a self-screening eligibility tool for medication abortion without an ultrasonogram.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>We designed a patient-administered, five-question screening tool (LMP-SURE) that assesses gestational age plus factors associated with misdating or ectopic pregnancy. We recruited participants without prior ultrasonograms from family planning clinics in Alaska, Hawai\u2018i, Idaho, and Utah to complete a brief survey including LMP-SURE and then obtained ultrasound dating by chart review. We compared eligibility for medication abortion by ultrasonogram with eligibility by the LMP-SURE screening tool.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>We consented 1,026 participants; 781 met eligibility requirements and completed the tool. Using the LMP-SURE tool, we identified 493 participants (65.1%) eligible for medication abortion without an ultrasonogram. The LMP-SURE tool sensitivity (ability to correctly identify a patient ineligible for medication abortion) was 83.8% (95% CI, 73.1\u201390.8), specificity (ability to correctly identify a patient eligible for medication abortion) was 70.0% (95% CI, 66.4\u201373.3), likelihood ratio (\u2212) (probability of someone eligible by LMP-SURE to be ineligible by ultrasonogram vs eligible by ultrasonogram) was 0.23 (95% CI, 0.13\u20130.40), and percentage of false-negatives was 1.5%. Only 11 patients (1.5%) who met eligibility for medication abortion without an ultrasonogram by the LMP-SURE tool were found ineligible for medication abortion by their ultrasonogram. Of those with conflicts, six (0.8%) had a gestational age beyond 77 days. The two participants (0.3%) diagnosed with ectopic pregnancies both required ultrasonograms by LMP-SURE.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>This patient-facing, brief, history-based screening tool can safely minimize the need for ultrasonogram before medication abortion.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000005675","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T21:00:57Z","timestamp":1721941257000},"page":"457-463","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Self-Determination of Eligibility for Medication Abortion Without Ultrasonography Using a History-Based Tool"],"prefix":"10.1097","volume":"144","author":[{"given":"Courtney","family":"Kerestes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Tschann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marit","family":"Pearlman Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Gawron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reni","family":"Soon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bliss","family":"Kaneshiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,7,25]]},"reference":[{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"e2122320","DOI":"10.1001\/jamanetworkopen.2021.22320","article-title":"Safety and efficacy of telehealth medication abortions in the US during the COVID-19 pandemic","volume":"4","author":"Upadhyay","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1001\/jama.2022.18865","article-title":"Requests for self-managed medication abortion provided using online telemedicine in 30 US states before and after the Dobbs v Jackson Women's Health Organization decision","volume":"328","author":"Aiken","year":"2022","journal-title":"JAMA"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.contraception.2021.04.028","article-title":"\u201cIt was close enough, but it wasn't close enough\u201d: a qualitative exploration of the impact of direct-to-patient telemedicine abortion on access to abortion care","volume":"104","author":"Kerestes","year":"2021","journal-title":"Contraception"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/AOG.0000000000004082","article-title":"Medication abortion up to 70 days of gestation. ACOG Practice Bulletin No. 225. American College of Obstetricians and Gynecologists","volume":"136","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jamainternmed.2022.0217","article-title":"Outcomes and safety of history-based screening for medication abortion: a retrospective multicenter cohort study","volume":"182","author":"Upadhyay","year":"2022","journal-title":"JAMA Intern Med"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/AOG.0000000000005016","article-title":"No-test medication abortion: a systematic review","volume":"141","author":"Pearlman Shapiro","year":"2023","journal-title":"Obstet Gynecol"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"710.e1","DOI":"10.1016\/j.ajog.2021.11.1373","article-title":"Accuracy of self-assessment of gestational duration among people seeking abortion","volume":"226","author":"Ralph","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.contraception.2020.04.005","article-title":"Commentary: no-test medication abortion: a sample protocol for increasing access during a pandemic and beyond","volume":"101","author":"Raymond","year":"2020","journal-title":"Contraception"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/1471-0528.16668","article-title":"Effectiveness, safety and acceptability of no-test medical abortion (termination of pregnancy) provided via telemedicine: a national cohort study","volume":"128","author":"Aiken","year":"2021","journal-title":"BJOG"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"h5527","DOI":"10.1136\/bmj.h5527","article-title":"STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies","volume":"351","author":"Bossuyt","year":"2015","journal-title":"BMJ"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1471-0528.2010.02753.x","article-title":"Alternatives to routine ultrasound for eligibility assessment prior to early termination of pregnancy with mifepristone-misoprostol","volume":"118","author":"Bracken","year":"2011","journal-title":"BJOG"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1097\/AOG.0000000000002560","article-title":"Tubal ectopic pregnancy. ACOG Practice Bulletin No. 193. American College of Obstetricians and Gynecologists","volume":"131","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R15-20250502","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.contraception.2015.04.008","article-title":"Early medical abortion without prior ultrasound","volume":"92","author":"Raymond","year":"2015","journal-title":"Contraception"},{"key":"R16-20250502","doi-asserted-by":"crossref","first-page":"P69","DOI":"10.1016\/j.contraception.2022.09.006","article-title":"An updated assessment of clinical outcomes of medication abortion without pretreatment ultrasonography","volume":"116","author":"Simons","year":"2022","journal-title":"Contraception"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000005675","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:50Z","timestamp":1746230450000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000005675"}},"subtitle":["LMP-SURE"],"short-title":[],"issued":{"date-parts":[[2024,7,25]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005675","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,25]]},"assertion":[{"value":"2024-03-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}